Delivery Order SPE2DB22D9130-SPE2DB24FE0CR
Award Date 1/24/24
Potential Completion Date 2/14/24
Potential Value $4.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $4,815.36 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $3,503.16 firm fixed-price contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS, with a completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract valued up to $4,999,999 with DLA under the SPE2DB program, which allows DLA to issue delivery orders for a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
- This is a $2,919.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS, with a completion date of March 5, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA, contract 4600082013 under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,478.76 contract is for the delivery of the pharmaceutical product KYLEENA 19.5 MG SYSTEMS, which is a contraceptive device. The contract has an ultimate completion date of April 29, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,611.58 firm fixed-price contract is for the delivery of the contraceptive device Kyleena 19.5mg. This contract is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place delivery orders for a wide range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $11,404.60, is for the delivery of the medical device KYLEENA 19.5 MG SYSTEMS. This contract is a task order under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. The IDC allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,436.28 contract is for the supply of the contraceptive device KYLEENA 19.5MG SYS 1S, with a period of performance through April 21, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,202.88 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a contraceptive device, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,611.58 contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a contraceptive product, to support the medical supply needs of military healthcare facilities. The award is under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
- SPE2DB22D9130Indefinite Delivery Contract
- SPE2DB22D9130-SPE2DB24FE0CRDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $4,815.36 firm fixed price contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. The delivery order was issued against an existing Indefinite Delivery, Indefinite Quantity (IDIQ) contract between DMS Pharmaceutical Group and DLA to provide a variety of pharmaceutical and medical products in support of military treatment facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on February 14, 2024.
Generated 4/24/24, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/24/24 |